Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects.

After experiencing many ups and downs, chimeric antigen receptor (CAR)-T cell therapy has reached a milestone as an anti-cancer method, as evidenced by the increasing number of clinical trials and approved products. Nonetheless, there is a real need to optimize CAR-T cell therapy and overcome its existing limitations. The importance of cellular starting material for generating CAR-T cells is undeniable, as the current personalized manufacturing approach is the main roadblock to providing a fast, affordable, and standard treatment for patients.

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review.

CAR-T cell therapy has shown remarkable promise in treating B-cell malignancies, which has sparked optimism about its potential to treat other types of cancer as well. Nevertheless, the Expectations of CAR-T cell therapy in solid tumors and non-B cell hematologic malignancies have not been met. Furthermore, safety concerns regarding the use of viral vectors and the current personalized production process are other bottlenecks that limit its widespread use.

The paths and challenges of "off-the-shelf" CAR-T cell therapy: An overview of clinical trials.

The advent of chimeric antigen receptor T cells (CAR-T cells) has made a tremendous revolution in the era of cancer immunotherapy, so that since 2017 eight CAR-T cell products have been granted marketing authorization. All of these approved products are generated from autologous sources, but this strategy faces several challenges such as time-consuming and expensive manufacturing process and reduced anti-tumor potency of patients' T cells due to the disease or previous therapies. The use of an allogeneic source can overcome these issues and provide an industrial, scalable, and standardized manufacturing process that reduces costs and provides faster treatment for patients.

Comparison of Maturity in Auditory-Visual Multisensory Processes With Sound-Induced Flash Illusion Test in Children and Adults.

Multi-sensory neural pathways of auditory-visual maturation develop before birth in humans. Maturation levels of multi-sensory brain pathways are very different in children in comparison to adults. Auditory sensory neural maturation occurs earlier than visual sensory neural maturation.

Can Pitch Mismatch Be Diagnosed in Children Who Use Electric-Acoustic Stimulation?

Introduction Pitch mismatch is one of the most important problems of users of bimodal cochlear implants, which affects their life satisfaction. Children with acquired hearing loss cannot explain their pitch mismatch problems, as they have had no auditory experience. This study tries to diagnose pitch mismatch in these children through the sound-induced flash illusion test.

Investigating the Effects of Hearing Loss and Hearing Aid Digital Delay on Sound-Induced Flash Illusion.

Background And Objectives: The integration of auditory-visual speech information improves speech perception; however, if the auditory system input is disrupted due to hearing loss, auditory and visual inputs cannot be fully integrated. Additionally, temporal coincidence of auditory and visual input is a significantly important factor in integrating the input of these two senses. Time delayed acoustic pathway caused by the signal passing through digital signal processing.

Acid-treated Fe-doped TiO as a high performance photocatalyst used for degradation of phenol under visible light irradiation.

The photocatalytic activity of Fe-doped TiO nanoparticles is significantly increased by an acid-treatment process. The photocatalyst nanoparticles were prepared using sol-gel method with 0.5 mol% ratio of Fe:Ti in acidic pH of 3.

Study of enzymatic degradation and water absorption of composites carboxymethyl cellulose and poly (ϵ-caprolactone) containing SiO2nanoparticle by cellulase.

This study investigates the effect of Poly (ϵ-Caprolactone (PCL) and Nano-SiO2content within the Carboxymethyl Cellulose (CMC) blends on the rate and extent of carboxymethyl cellulose enzymatic hydrolysis using the enzyme cellulase. The results reveal that blends with Nano-SiO2content at 5 wt% exhibit a significantly reduced rate and extent of CMC hydrolysis. This may be attributed to interactions between CMC and SiO2that prevent further enzymatic attack on the remaining CMC phases within the blend.